Volitionrx (VNRX) Share-based Compensation Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.38% |
| Jun 30, 2025 | 15.93% |
| Mar 31, 2025 | 22.23% |
| Dec 31, 2024 | -25.93% |
| Sep 30, 2024 | 19.69% |
| Jun 30, 2024 | -11.23% |
| Mar 31, 2024 | 3.98% |
| Dec 31, 2023 | -7.68% |
| Sep 30, 2023 | 2.00% |
| Jun 30, 2023 | 3.73% |
| Mar 31, 2023 | -4.97% |
| Dec 31, 2022 | 3.06% |
| Sep 30, 2022 | 1.04% |
| Jun 30, 2022 | 6.06% |
| Mar 31, 2022 | 9.39% |
| Dec 31, 2021 | -13.52% |
| Sep 30, 2021 | 7.83% |
| Jun 30, 2021 | -4.57% |
| Mar 31, 2021 | 29.47% |
| Dec 31, 2020 | -4.40% |
| Sep 30, 2020 | -4.83% |
| Jun 30, 2020 | 23.54% |
| Mar 31, 2020 | -11.01% |
| Dec 31, 2019 | 29.81% |
| Sep 30, 2019 | -36.66% |
| Jun 30, 2019 | 108.59% |
| Mar 31, 2019 | 49.13% |
| Dec 31, 2018 | 65.72% |
| Sep 30, 2018 | 21.83% |
| Jun 30, 2018 | 42.87% |
| Mar 31, 2018 | 60.58% |
| Dec 31, 2017 | 117.14% |
| Sep 30, 2017 | 42.39% |
| Jun 30, 2017 | 36.52% |
| Mar 31, 2017 | 23.03% |
| Dec 31, 2016 | 103.22% |
| Sep 30, 2016 | 16.62% |
| Jun 30, 2016 | 23.90% |